GlaxoSmithKline PLC (LSE:GSK) - Share price - Overview

Stock Report

GlaxoSmithKline PLC GSK

Last Price
GBX1,611.00

Day Change
16.50|1.03%

As of 16/02/2017
09:48:29 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,594.50p
Day Range1,601.00 - 1,615.50
Mkt Cap78.29Bil
52-Wk Range1,355.00 - 1,745.56
Yield %4.97
ISINGB0009252882
Volume2,129,600
P/E13.20
P/S3.25
P/CF40.73

Share Price

Total Returns 15/02/2017

 Chg (%)  
More ...
GlaxoSmithKline PLC0.57 
FTSE 100 TR GBP-0.41
 
Financials
201420152016
More ...
Income Statement
Turnover23,006.0023,923.00-
Operating Profit3,597.0010,322.00-
Net Profit2,831.008,372.00-
Reported EPS56.70172.30-
Balance Sheet
Current Assets13,522.0016,541.00-
Non Current Assets25,973.0036,859.00-
Total Assets40,651.0053,446.00-
Current Liabilities13,295.0013,417.00-
Total Liabilities35,715.0044,568.00-
Total Equity4,936.008,878.00-
Cash Flow
Operating Cash Flow6,284.004,631.00-
Net Change in Cash-1,287.001,503.00-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20176,160.17106.35-12.8414.99-1.1780.005.02
20188,553.20104.80-1.4615.22-10.3980.005.02

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/02/2017Transfer OutSir Andrew Witty0.0063,4410.00
09/02/2017PurchaseSir Andrew Witty1,583.368127.00
09/02/2017Transfer inSir Andrew Witty0.0080.00
09/02/2017PurchaseMr. Simon Dingemans1,583.368127.00

Company Profile

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Sector

Drug Manufacturers - Major

Market Position

5 of 1851 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE Eurotop 100 ,S&P Europe 350 ,Eurotop 300

Outlook

(08/02/2017) "...we remain confident in the financial outlook we have previously set out for investors"

Next Event 23/02/2017

Ex Dividend
Ratios
CompSecMkt
More ...
PER (E)15.0214.254.71
Div Yld (E)5.023.864.04
PEG (E)-1.30-0.321.56
ROCE0.00197.40-33.01
Op Mrgn0.00-13.43-18.15
EPS Grwth-11.5718.8726.98
Dividends
PreviousLatest
More ...
Record Date04/11/1624/02/17
Ex-Div03/11/1623/02/17
Paid12/01/1713/04/17
Amnt19.0023.00

Broker Sentiment

Strong Buy0
Buy2
Hold2
Sell1
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Philip Hampton
Chief Executive OfficerSir Andrew Witty
Chief Financial OfficerMr. Simon Dingemans
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.